FIELD: medicine.
SUBSTANCE: invention relates to medicine and pharmacology and represents pharmaceutical composition, which possesses anti-inflammatory activity, contains calcitonin and glucocorticoid in therapeutically effective quantities and pharmaceutically acceptable carrier.
EFFECT: invention ensures synergetic action of calcitonin with prednisolone, which allows to reduce required doze of prednisolone at least fivefold, and thus potentially avoid adverse side effects of high doses of steroids.
11 cl, 1 ex, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR AUTOIMMUNE AND INFLAMMATORY DISEASES TREATMENT | 2012 |
|
RU2639540C2 |
| COMBINATION DRUG CONTAINING CORTICOSTEROID AND EXOSOMES | 2010 |
|
RU2557897C2 |
| COMBINATIONS FOR TREATMENT OF INFLAMMATORY DISEASES | 2002 |
|
RU2300379C2 |
| GM-CSF-NEUTRALIZING ANTIBODIES FOR USE IN TREATING RHEUMATOID ARTHRITIS OR AS ANALGESICS | 2014 |
|
RU2714919C2 |
| COMPOSITION FOR TREATING DISEASE | 2009 |
|
RU2531548C2 |
| BLOCKING OF INFLAMMATORY PROTEASES BY THETA-DEFENSINS | 2012 |
|
RU2652605C2 |
| TREATING AUTOIMMUNE DISEASES WITH CD154 ANTIBODIES | 2015 |
|
RU2695443C2 |
| COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES | 2010 |
|
RU2569109C2 |
| ANTIBODIES AGAINST TNF-α AND USE THEREOF | 2010 |
|
RU2595379C2 |
| COMPOSITION FOR TREATING ARTHRITIS | 2009 |
|
RU2563360C2 |
